Skip to content

The Effect of Different Treatment Modalities of Tubal Ectopic Pregnancy on Ovarian Reserve: a Prospective Cohort Study

The Effect of Different Treatment Modalities of Tubal Ectopic Pregnancy on Ovarian Reserve: a Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06471166
Enrollment
90
Registered
2024-06-24
Start date
2024-07-10
Completion date
2025-10-10
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ectopic Pregnancy

Brief summary

Detect the effect of different treatment modalities of tubal ectopic pregnancy on ovarian reserve

Interventions

DIAGNOSTIC_TESTAmh hormone

Ovarian reserve

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 44 Years

Inclusion criteria

* The study will include patients aged 18-44 years with known diagnosis or suspicion of diagnosis of tubal ectopic pregnancy (abnormal doubling rates of their b-HCG levels as well as ultrasonographically identified or unidentified gestational sacs outside the uterus) * Included patients must have capacity to provide informed consent. Given the potential emergent nature of presentation, women will not be recruited if fully informed consent could be compromised due to a highly distressed emotional state or significant hemorrhage necessitating the need for urgent surgery

Exclusion criteria

1. The use of hormonal contraceptives within two months of enrolment 2. If other surgery was conducted at the time of salpingectomy. 3. If a woman was pregnant at follow up visit for AMH measurement 4. History of previous surgeries of fallopian tubes and/or ovaries

Design outcomes

Primary

MeasureTime frame
Change in levels of AMH pre and post treatment3 months

Countries

Egypt

Contacts

Primary ContactAndro Bahgat, MD
androbahgat7@gmail.com01283104773

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026